oversulfated

Chinese officials have disputed the FDA's finding that the contaminant was a substance called oversulfated chondroitin sulfate.

China Never Investigated Tainted Heparin, Says Probe 2010

An FDA task force that included drug-industry researchers said the adulterant was oversulfated chondroitin sulfate, a substance that increases the potency of heparin and makes it more valuable.

House Investigates Heparin Crisis Alicia Mundy 2011

Baxter tests on the Delaware incidents didn't detect a contaminant found in last year's heparin-illness outbreak, oversulfated chondroitin sulfate.

Heparin Stirs New Fears 2009

"We presume it is the same contaminant," oversulfated chondroitin sulfate, as found in batches of heparin in the U.S., "but it has yet to be definitively confirmed," he said.

Three More European Countries Recall Heparin Jeanne Whalen, Thomas M. Burton 2008

Earlier this week, the U.S. Food and Drug Administration identified the contaminant in heparin batches from a Chinese supplier to U.S. pharmaceuticals company Baxter International Inc. as oversulfated chondroitin sulfate.

Archive 2008-03-01 Jan 2008

Last month, the FDA said some of the heparin contained oversulfated chondroitin sulfate, an altered version of chondroitin sulfate that is used as a dietary supplement and is typically made from animal cartilage.

Economic Fraud Suspected 2008

But both the U.S. and Chinese drug agencies said they were investigating how the oversulfated chondroitin sulfate, which does not occur naturally, got into the heparin batches.

Archive 2008-03-01 Jan 2008

The FDA has said it doesn't yet know how or when the contaminated ingredient, oversulfated chondroitin sulfate, was put into the supply.

FDA Withholds List of Chinese 2008

The contaminant – oversulfated-chondroitin sulfate – is much more plentiful in the animal, but isn't approved for medical use because it can cause severe allergic reactions in humans.

China's Drug Dilemma 2008

According to the guidance document, contamination involving the chemical at issue -- oversulfated chondroitin sulfate OSCS -- appears intentional to save costs.

Yahoo! News: Business - Opinion 2012